MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0027850
Titan Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹332.25 Cr
Latest filing
Net profit · FY 2025
₹57.22 Cr
Net margin 17.2%
EBITDA · FY 2025
₹91.56 Cr
EBITDA margin 27.6%
Authorised capital
₹45 Cr
Registered with MCA
Paid-up capital
₹41.33 Cr
Issued & subscribed
Open charges
₹79.6 Cr
Satisfied ₹11.43 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
305
Provident fund records
About Titan Laboratories Private Limited
Data last updated:
Titan Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2004PTC146928. Its GSTIN is 27AACCT0509Q1Z2 (Maharashtra).
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹41.33 Cr. It is led by directors Piyush Bhailal Shah (Managing Director) and Deepak Bhailal Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹332.25 Cr. For the same year it recorded a net profit of ₹57.22 Cr (net margin 17.2%) and EBITDA of ₹91.56 Cr (EBITDA margin 27.6%).
The company has about 305 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Titan-Laboratories. As per MCA filings, the company has open charges of ₹79.6 Cr and satisfied charges of ₹11.43 Cr on record. Court records list 22 cases involving the company, including 8 filed by the company and 11 filed against it; 4 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Geno Pharmaceuticals Private Limited with revenue of ₹349.47 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2023, listing 64 overdue payments to 48 micro and small suppliers.
Titan Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0027850). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website titan-lab.com.
Company Details of Titan Laboratories Private Limited
CIN U24100MH2004PTC146928
Registration Number 146928
Incorporation Date 14 June 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0027850
Recognitions & Rankings of Titan Laboratories
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA/01 – GF & A/101 Plot No.120 Anand Bhavan Spectrum Building R B Mehta Marg Tilak, Road, Mumbai, Maharashtra, India – 400077
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Titan Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Titan Laboratories Private Limited
Titan Laboratories operates one associated brand: Titan-Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Titan Laboratories is a contract manufacturer of active ingredients for nutraceuticals and pharmaceuticals. | titan-lab.com |
Business Activity of Titan Laboratories Private Limited
The main business activity of Titan Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Titan Laboratories Private Limited FY 2025 filings available
Titan Laboratories Private Limited reported revenue of ₹332.25 Cr for FY 2025.
Revenue · FY 2025
₹332.25 Cr
Net profit · FY 2025
₹57.22 Cr margin 17.2%
EBITDA · FY 2025
₹91.56 Cr margin 27.6%
Financial Statement Summary of Titan Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹91.56 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹57.22 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Titan Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 17.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Titan Laboratories are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Titan Laboratories Private Limited
Titan Laboratories has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bhailal Shah | Whole-Time Director | 01 Apr 2008 | 18 Years 6 Months | Current |
| Piyush Bhailal Shah | Managing Director | 14 Jun 2004 | 22 Years 4 Months | Current |
Peer Comparison of Titan Laboratories Private Limited
Titan Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Geno Pharmaceuticals Private Limited | ₹349.47 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Goa, India |
| Sparsh Bio-Tech Private Limited | ₹346.49 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Jamnagar, Gujarat, India |
| Capsugel Healthcare Private Limited | ₹340.69 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Gurugram, Haryana, India |
| Walter Bushnell Enterprises Private Limited | ₹340.47 Cr (FY 2025) | •••• | •••• | 132.0% | •••• | Mumbai, Maharashtra, India |
| Ozone Pharmaceuticals Limited | ₹337.45 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
| Titan Laboratories Private Limited this company | ₹332.25 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sainor Laboratories Private Limited | ₹328.35 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Hyderabad, Telangana, India |
| Softgel Healthcare Private Limited | ₹327.36 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Puduppakkam, Tamil Nadu, India |
| Veiva Scientific India Private Limited | ₹325.41 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Overseas Health Care Private Limited | ₹323.03 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Punjab, India |
| Gopaldas Visram and Company Limited | ₹322.71 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Mumabi, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Titan Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Titan Laboratories Private Limited
Titan Laboratories Private Limited is audited by RAJESH J SHAH & ASSOCIATES for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH J SHAH & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Titan Laboratories Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Titan Laboratories Private Limited
Open charges
₹79.6 Cr
Satisfied charges
₹11.43 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2023 | Others | ₹20 Lakh | Open |
| 06 Jan 2023 | Others | ₹20 Cr | Open |
| 16 Jan 2020 | Others | ₹7.2 Cr | Open |
| 01 Oct 2014 | The Ratnakar Bank Limited | ₹3.25 Cr | Open |
| 22 Aug 2014 | Others | ₹23.1 Cr | Open |
Total charge records: 12 View all charges
Deals & Funding of Titan Laboratories Private Limited
Titan Laboratories Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹89.1 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2007 | Funding round | ₹89.1 Lakh | Investors: 4 individuals |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Titan Laboratories Private Limited
Titan Laboratories Private Limited has 22 court cases on record: 8 filed by Titan Laboratories, 11 filed against it, 3 where it is another party. 4 cases are pending and 18 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Total cases
22
Filed by the company
8
Filed against the company
11
Pending
4
Disposed
18
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 10 | 3 | 4 |
| District courts | 10 | 6 | 0 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (APEAL) | Filed by the company against Gena Pharmaceuticals Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Gena Pharmaceuticals Limited | Disposed |
| Bombay High Court | Court case (ALP) | Filed by the company against Gena Pharmaceuticals Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed by the company against Gena Pharmaceuticals Limited | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by Prinicipal Commissioner of Income Tax 6 Mumbai | Pending |
Premium access
Full case history
All 22 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Titan Laboratories Private Limited
Titan Laboratories Private Limited has 3 MSME Form 1 returns on record between 2019 and 2023, listing 64 overdue payments to 48 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 48)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ankit Pulps and Boards Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Agarwal Life Sciences Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Titan Laboratories Private Limited
Titan Laboratories Private Limited has a workforce of 305 employees as of Oct 07, 2025.
Employee count
305
Active EPFO establishments
1
Employee growth
2.35%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Titan Laboratories Private Limited
Titan Laboratories has 1 subsidiary company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Titan Pharmaplus Private Limited | U51397MH2022PTC378007 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Titan Laboratories Private Limited
Titan Laboratories Private Limited has 7 board changes on record since 2004: 2 appointments and 5 cessations. The latest: Bhailal Babulal Shah ceased to be Whole-Time Director on 23 Dec 2021.
AGM
Titan Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Titan Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others of Rs. 20.00 Cr registered on 06 Jan 2023 with Charge ID 100668733 was modified on 12 Jun 2024.
Charges
A charge with Others of Rs. 23.10 Cr registered on 22 Aug 2014 with Charge ID 10517240 was modified on 23 Mar 2023.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100668725 was registered on 06 Jan 2023.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100668733 was registered on 06 Jan 2023.
Charges
A charge with Others of Rs. 25.85 Cr registered on 22 May 2013 with Charge ID 10429702 was modified on 17 Feb 2022.
Ceased
Bhailal Babulal Shah ceased to be Whole-Time Director.
Ceased
Hiromi Deepak Shah ceased to be Whole-Time Director.
Ceased
Virendra Babulal Shah ceased to be Director.
Charges
A charge with Others amounted to Rs. 7.20 Cr with Charge ID 100316164 was registered on 16 Jan 2020.
Charges
A charge with The Ratnakar Bank Limited amounted to Rs. 3.25 Cr with Charge ID 10527695 was registered on 01 Oct 2014.
22 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Titan Laboratories Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Titan Laboratories Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Titan Laboratories Private Limited
Titan Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCT0509Q1Z2 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Titan Laboratories Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Titan Laboratories Private Limited
Frequently Asked Questions about Titan Laboratories Private Limited
Titan Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2004 (22+ years old) and is registered under CIN U24100MH2004PTC146928.
Titan Laboratories reported revenue of ₹332.25 Cr for FY 2025.
Titan Laboratories has 2 current directors:
- Piyush Bhailal Shah - Managing Director
- Deepak Bhailal Shah - Whole-Time Director
Titan Laboratories reported a net profit of ₹57.22 Cr (net margin 17.2%) and EBITDA of ₹91.56 Cr (EBITDA margin 27.6%) for FY 2025, as per its filed financial statements.
The GSTIN of Titan Laboratories is 27AACCT0509Q1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Titan Laboratories is U24100MH2004PTC146928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Titan Laboratories has 22 court cases on record: 8 filed by the company and 11 filed against it. 4 are pending. Most are in the high courts.
Titan Laboratories was incorporated on 14 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Titan Laboratories has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024.
The peers of Titan Laboratories by revenue are Geno Pharmaceuticals Private Limited, Sparsh Bio-Tech Private Limited, Capsugel Healthcare Private Limited, Walter Bushnell Enterprises Private Limited, Ozone Pharmaceuticals Limited and 5 more, all in the Pharma industry (Formulations).
Bhailal Babulal Shah ceased to be Whole-Time Director on 23 Dec 2021. Hiromi Deepak Shah ceased to be Whole-Time Director on 23 Dec 2021. Virendra Babulal Shah ceased to be Director on 24 Apr 2020. Titan Laboratories has 7 board changes on record in total.
Yes, Titan Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0027850).